|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
22,260,000 |
Market
Cap: |
11.21(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.5036 - $0.5036 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile PDS Biotechnology is a clinical-stage immunotherapy company developing a pipeline of molecularly targeted immunotherapies designed to overcome the limitations of existing immunotherapy and vaccine technologies. Co. owns the proprietary T-cell activating platforms designed to train the immune system to attack and destroy disease; Versamune®, for treatments in oncology and Infectimune, for treatments in infectious disease. Infectimune is also designed to promote the induction of disease-specific neutralizing antibodies. Co. is developing targeted product candidates to treat cancers including Human Papillomavirus associated cancers, melanoma, colorectal, lung, breast and prostate cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Leuthner Brian A |
President and CEO |
|
2017-12-04 |
4 |
AS |
$9.97 |
$24,925 |
D/D |
(2,500) |
92,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-12-01 |
4 |
AS |
$9.92 |
$24,800 |
D/D |
(2,500) |
95,236 |
|
- |
|
Marchio Albert N Ii |
Chief Accounting & Adm Officer |
|
2017-11-22 |
4 |
S |
$10.00 |
$33,610 |
D/D |
(3,361) |
0 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-11-03 |
4 |
AS |
$10.86 |
$27,150 |
D/D |
(2,500) |
97,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-11-02 |
4 |
AS |
$10.94 |
$27,350 |
D/D |
(2,500) |
100,236 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-11-01 |
4 |
AS |
$10.92 |
$27,300 |
D/D |
(2,500) |
102,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-10-04 |
4 |
AS |
$11.14 |
$27,850 |
D/D |
(2,500) |
105,236 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-10-03 |
4 |
AS |
$10.93 |
$27,325 |
D/D |
(2,500) |
107,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-10-02 |
4 |
AS |
$10.81 |
$27,025 |
D/D |
(2,500) |
110,236 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-09-06 |
4 |
AS |
$10.31 |
$25,775 |
D/D |
(2,500) |
112,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-09-05 |
4 |
AS |
$9.94 |
$24,850 |
D/D |
(2,500) |
115,236 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-09-01 |
4 |
AS |
$10.37 |
$25,925 |
D/D |
(2,500) |
117,736 |
|
- |
|
Marchio Albert N Ii |
Chief Accounting & Adm Officer |
|
2017-08-29 |
4 |
S |
$10.42 |
$26,050 |
D/D |
(2,500) |
3,361 |
|
- |
|
Marchio Albert N Ii |
Chief Accounting & Adm Officer |
|
2017-08-23 |
4 |
S |
$10.39 |
$10,390 |
D/D |
(1,000) |
5,861 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-08-03 |
4 |
AS |
$10.40 |
$26,000 |
D/D |
(2,500) |
120,236 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-08-02 |
4 |
AS |
$10.53 |
$26,325 |
D/D |
(2,500) |
122,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-08-01 |
4 |
AS |
$10.65 |
$26,625 |
D/D |
(2,500) |
125,236 |
|
- |
|
Barer Sol J |
Director |
|
2017-07-07 |
4 |
OE |
$2.39 |
$29,947 |
I/I |
12,530 |
658,075 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-07-06 |
4 |
AS |
$10.08 |
$25,200 |
D/D |
(2,500) |
127,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-07-05 |
4 |
AS |
$10.21 |
$25,525 |
D/D |
(2,500) |
130,236 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-07-03 |
4 |
AS |
$10.27 |
$25,675 |
D/D |
(2,500) |
132,736 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-04-26 |
4 |
AS |
$11.10 |
$1,110 |
D/D |
(100) |
135,236 |
|
- |
|
Loughlin James J |
Director |
|
2017-03-06 |
4 |
B |
$9.24 |
$27,720 |
I/I |
3,000 |
6,000 |
2.1 |
- |
|
Einhorn Andrew J. |
Chief Financial Officer |
|
2017-03-01 |
4 |
OE |
$2.39 |
$3,745 |
D/D |
1,567 |
43,223 |
|
- |
|
Leuthner Brian A |
President and CEO |
|
2017-02-07 |
4 |
AS |
$9.52 |
$14,280 |
D/D |
(1,500) |
245,479 |
|
- |
|
122 Records found
|
|
Page 3 of 5 |
|
|